Recruiting · registry status

Curcumin for symptoms and wellbeing

Researchers are testing a preparation derived from turmeric and measuring fatigue, sleep and quality of life in Parkinson's.

Testing a treatment or activity · Study reference: IRCT20101209005352N2

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported date): 2018-08-23

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded

2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Age 35 years and over · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: both

Inclusion criteria: Idiopathic Parkinson disease (MDS-PD Criteria) At least elementary education Filling up the consent form for each patient Unified Parkinson's Disease Rating Scale (Hoehn &Yahr) (I- III) No change in drug and supplement therapy since last month 35 yrs and over No reported allergy to turmeric and other foods and supplements Parkinson's disease history <10 years Exclusion criteria: Abnormal renal and liver function tests Cognitive disorders, epilepsy, stroke, and other cerebral diseases Severe disability caused by dementia or other diseases Gastric disorders, GE reflux and gastric ulcers

Full study name & original research details

Official study title

The effectiveness of curcumin nanomicelles on quality of life, severity of illness, fatigue and sleep quality in Parkinson's patients

Short title used by the registry

The effectiveness of curcumin on quality of life, severity of illness, fatigue and sleep quality in Parkinson's patients

Original description

Intervention: Intervention 1: ""Intervention group"": Parkinson patients, two soft gelatin Sina-curcumin nanomicelle capsules of 80 mg after breakfast and dinner for three month , Exir Nano Sina company, Minoo comany, Curcumin the yellow pigment in curry spice , Tumeric, is the principal curcuminoid in the rhizome of Curcumia longa Linn. Curcumin has effects similar to other polyphenols (diarylheptanoid). In combination with other main curcuminoids including desmethoxycurcumin, bis-desmethoxycurumin, they form 3-5% ofdried tumeric powder. Intervention 2: ""Control group"": Parkinson patients, two soft gelatin placebo Sina-curcumin nonomicelle capsules of 80 mg after breakfast and dinner for three month, Exir Nano Sina company, Minoo company. Primary outcome: Quality of life based on the PDQ-39 questionnaire. Timepoint: Filling up the questionnaire for each patient at the beginning of the study and three months later. Method of measurement: The quality of life based on the PDQ-39. Secondary outcome: Sleep quality. Timepoint: Filling up the questionnaire for each patient at the beginning of the study and three month later. Method of measurement: The sleep quality based on PSQI questionnaire.;Fatigue. Timepoint: Filling up the questionnaire for each patient at the beginning of the study and three month later. Method of measurement: The fatigue based on FSS questionnaire.

Conditions reported: Parkinson's disease. Parkinson's disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

IRCT · IRCT20101209005352N2 ↗ — Recruiting; WHO ICTRP processed 2018-09-11; checked 2026-10-14

Study type: Interventional
Interventions: Intervention 1: ""Intervention group"": Parkinson patients, two soft gelatin Sina-curcumin nanomicelle capsules of 80 mg after breakfast and dinner for three month , Exir Nano Sina company, Minoo comany, Curcumin the yellow pigment in curry spice , Tumeric, is the principal curcuminoid in the rhizome of Curcumia longa Linn. Curcumin has effects similar to other polyphenols (diarylheptanoid). In combination with other main curcuminoids including desmethoxycurcumin, bis-desmethoxycurumin, they form 3-5% ofdried tumeric powder. Intervention 2: ""Control group"": Parkinson patients, two soft gelatin placebo Sina-curcumin nonomicelle capsules of 80 mg after breakfast and dinner for three month, Exir Nano Sina company, Minoo company.
Phases: 3
Sponsor: Zanjan University of Medical Sciences
Start date reported by registry: 2018-08-23 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-14 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Mehdi Maghbooli · +98 24770801 · m.maghbooli@zums.ac.ir

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

Iran (Islamic Republic of)

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.